Braveheart Bio Earnings
NASDAQ: BRVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
20.02+0.93 (+4.87%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Braveheart Bio earnings summary
In its most recent report on Sep 8, 2026 (Q2 2026), BRVE posted EPS of $-2.51.
Summary generated from market data by MetaCap's automated system. Methodology
BRVE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Sep 8, 2026 | — | $-2.51 | — | +9.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.